Trevi Therapeutics (TRVI) Operating Leases (2018 - 2026)
Trevi Therapeutics' quarterly Operating Leases came in at $364000.0 in Q1 2026, down 46.55% year-on-year from $681000.0 in Q1 2025, and down 18.39% quarter-over-quarter from $446000.0 in Q4 2025.
Trevi Therapeutics has reported Operating Leases for 9 years, with the latest figure at $364000.0 in Q1 2026.
- For the quarter ending Q1 2026, Operating Leases fell 46.55% year-over-year to $364000.0; the trailing twelve-month figure through Mar 2026 stood at $364000.0 (down 46.55% YoY), and the FY2025 full-year result was $446000.0, down 40.29% from the prior year.
- Operating Leases for Q1 2026 stood at $364000.0, down from $446000.0 in the prior quarter.
- The five-year high for Operating Leases was $1.1 million in Q1 2023, with the low at $2000.0 in Q3 2022.
- Average Operating Leases over 5 years is $645375.0, with a median of $714000.0 recorded in 2024.
- Year-over-year, Operating Leases tumbled 96.7% in 2022 and jumped 52450.0% in 2023.
- Tracing TRVI's Operating Leases over 5 years: stood at $2000.0 in 2022, then soared by 49950.0% to $1.0 million in 2023, then dropped by 25.37% to $747000.0 in 2024, then tumbled by 40.29% to $446000.0 in 2025, then declined by 18.39% to $364000.0 in 2026.
- The last three Operating Leases figures came in at $364000.0 (Q1 2026), $446000.0 (Q4 2025), and $527000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Trevi Therapeutics | 2.02 Bn | 1.85 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 364,000.00 |
| Dec 31, 2025 | 446,000.00 |
| Sep 30, 2025 | 527,000.00 |
| Jun 30, 2025 | 605,000.00 |
| Mar 31, 2025 | 681,000.00 |
| Dec 31, 2024 | 747,000.00 |
| Sep 30, 2024 | 816,000.00 |
| Jun 30, 2024 | 884,000.00 |
| Mar 31, 2024 | 949,000.00 |
| Dec 31, 2023 | 1.00 Mn |
| Sep 30, 2023 | 1.05 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.15 Mn |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Dec 31, 2021 | 24,000.00 |
| Sep 30, 2021 | 58,000.00 |
| Jun 30, 2021 | 91,000.00 |
| Mar 31, 2021 | 123,000.00 |
| Dec 31, 2020 | 144,000.00 |
| Sep 30, 2020 | 173,000.00 |
| Jun 30, 2020 | 202,000.00 |
| Mar 31, 2020 | 230,000.00 |
| Dec 31, 2019 | 257,000.00 |
| Sep 30, 2019 | 283,000.00 |
| Jun 30, 2019 | 308,000.00 |
| Mar 31, 2019 | 333,000.00 |
| Dec 31, 2018 | 46,000.00 |